Post-earnings recap
Reported
Tue, Feb 3, 2015
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
The earnings report indicates that Edwards Lifesciences performed better than expected on EPS, which likely contributed to the 1.21% increase in stock price. Investors may view the strong EPS as a positive sign of the company's profitability, even in the absence of revenue figures. The focus on innovation suggests that the company is positioning itself for future growth.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.06 | N/A | +12.53% |
| Revenue | N/A | N/A | N/A |
Management is pleased with the EPS results but did not provide specific revenue details. They emphasized their commitment to innovation.
Management expressed satisfaction with the EPS performance despite not providing revenue figures.
They highlighted ongoing investments in innovation as a key focus for the future.